Rectal Adenocarcinoma clinical trials

Explore recruiting rectal adenocarcinoma clinical trials.

Recruiting rectal adenocarcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Rectal Adenocarcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase II Clinical Trial of KORTUC (KRC-01) Combined with Radiotherapy for Locally Advanced Rectal Cancer: Towards a New Organ Preservation Approach (K-BOOST)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Multicenter randomized Phase III trial evaluating contact X-ray brachytherapy for rectal preservation in intermediate substage rectal adenocarcinoma (TRESOR)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Evaluation of 64Cu-ATSM PET/CT as a predictor of response to neoadjuvant therapy in locally advanced rectal cancer (TEP-64Cu-ATSM-Rectum)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

NACRE 2_Randomized phase III study evaluating two treatment strategies for locally advanced rectal cancer in patients ≥75 years old

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prophylaxis of venous thromboembolic disease with LMWH (TINzaparin) in patients with metastatic colorectal cancer who start the first line of treatment.

Spain, Portugal

Therapeutic confirmatory (Phase III) EU CTIS Study details

Rectal Adenocarcinoma trials by city

Rectal Adenocarcinoma in Toronto Rectal Adenocarcinoma in Vancouver Rectal Adenocarcinoma in Montreal Rectal Adenocarcinoma in Calgary Rectal Adenocarcinoma in Edmonton Rectal Adenocarcinoma in Ottawa Rectal Adenocarcinoma in Winnipeg Rectal Adenocarcinoma in Quebec City Rectal Adenocarcinoma in Hamilton Rectal Adenocarcinoma in Kitchener Rectal Adenocarcinoma in London Rectal Adenocarcinoma in Halifax Rectal Adenocarcinoma in New York Rectal Adenocarcinoma in Los Angeles Rectal Adenocarcinoma in Chicago Rectal Adenocarcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease